MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Over 23 million Americans suffer from autoimmune diseases, such as rheumatoid arthritis, lupus, thyroid disease, fibromyalgia, etc. These diseases occur when the immune system stops playing the role of defense Mechanism and begins to attack the body instead. The immune system attacks cells, tissues, and
Regenerative medicine isn’t exactly a household word yet, but it’s well on the way to becoming one in the next few years. Regenerative medicine has provided patients with all sorts of long-term relief from symptoms that were often believed to be incurable or, at the
Debates regarding the potency and benefits of one type of stem cell over another aren’t your everyday dinner table conversation. However, these discussions are important for anybody who is considering stem cell treatment. There are many different stem cell types to choose from, and two
As stem cell therapy becomes more popular for its effectiveness in treating various diseases and conditions, more attention is also being given to other forms of regenerative medicine, including platelet-rich plasma therapy. As stem cell therapy, platelet-rich plasma therapy can be used to treat a
Hip arthritis is a very common condition in the United States. In fact, over 20% of people in the United States suffer from hip arthritis and the associated pain. Many people who suffer from hip arthritis attempt some form of treatment whether that be in
Tendonitis is a very common ailment amongst those in the United States. Tendons are a flexible, yet inelastic cord of strong tissue that attaches muscles to bones. Due to a variety of reasons, tendons in the body can become inflamed leading to tendonitis. While tendonitis
Cardiomyopathy is a condition that oftentimes goes unnoticed or undiagnosed. Therefore, it is difficult to tell exactly how many people in the United States suffer from the condition. It is thought that 1 in every 500 people in the United States is suffering from the
Established in 2012 and spearheaded by David Greene, R3 Stem Cell is delivering effective and safe regenerative therapies in the US & internationally. The company offers products and services internationally to both patients and providers. It has clinics that provide regenerative therapies, along with training
Stem cell therapy is becoming known as one of the most effective non-invasive therapies on the planet. It’s an extremely versatile form of treatment that can help people recover from all manner of conditions. Bone marrow derived stem cell (BMC) treatments are among the most
FDA 361 Compliant Umbilical Cord Wharton’s Jelly Allograft Tissue Umbilical cord allograft tissue made with Wharton’s Jelly can be compliant with current FDA 361 regulations. While many doctors/clinics using autologous bone marrow or adipose tissue would like you to believe none of it is compliant,
